First Republic Investment Management, Inc. Nektar Therapeutics Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $142,358 - $205,205	-10,892 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $3,551 - $4,386	-215 Reduced 1.94%	10,892 $187,000
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $7,981 - $12,271	-482 Reduced 4.16%	11,107 $222,000
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $43,241 - $52,180	-2,742 Reduced 19.13%	11,589 $197,000
Q3 2020 Nov 12, 2020	BUY	$16.59 - $24.79 $3,168 - $4,734	191 Added 1.35%	14,331 $238,000
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $6,693 - $9,305	-397 Reduced 2.73%	14,140 $327,000
Q1 2020 May 13, 2020	BUY	$14.47 - $27.96 $44,900 - $86,759	3,103 Added 27.14%	14,537 $259,000
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $32,041 - $46,679	-2,019 Reduced 15.01%	11,434 $247,000
Q3 2019 Nov 08, 2019	SELL	$16.91 - $36.27 $16,910 - $36,270	-1,000 Reduced 6.92%	13,453 $245,000
Q2 2019 Aug 07, 2019	BUY	$31.0 - $36.3 $4,061 - $4,755	131 Added 0.91%	14,453 $514,000
Q1 2019 Apr 30, 2019	BUY	$31.58 - $46.35 $7,958 - $11,680	252 Added 1.79%	14,322 $481,000
Q4 2018 Feb 12, 2019	SELL	$30.43 - $56.65 $96,280 - $179,240	-3,164 Reduced 18.36%	14,070 $462,000
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $74,893 - $110,405	1,612 Added 10.32%	17,234 $1.05 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $116,966 - $264,154	2,529 Added 19.32%	15,622 $763,000
Q1 2018 May 10, 2018	SELL	$57.4 - $108.44 $459,085 - $867,303	-7,998 Reduced 37.92%	13,093 $1.39 Million
Q4 2017 Feb 09, 2018	SELL	$23.02 - $60.5 $109,874 - $288,766	-4,773 Reduced 18.45%	21,091 $1.26 Million
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $460,120 - $620,736	25,864	25,864 $620,000

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$16.7 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$15.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$13.8 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$9.87 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.66 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $197M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account